drugset / Trial / NCT01551823
The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) （Children Forms of Drug）
Phase 3
Completed
1200 enrolled
Institute of Medical Biology, Chinese Academy of Medical Sciences
Hebei Provincial Center for Diseases Control and Prevention · collab
RandomizedParallel-groupSingle-blindPrevention
Summary
The purpose of this study is to evaluate the safety and the immunogenicity of Influenza Virus Vaccine (Split Virion, Inactivated)(children forms of drug) that do not contains Preservative.
Timeline
- Start
- 2012-03
- Primary completion
- 2012-05
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Influenza Virus Vaccine | Vaccine | 0.25 ml | Intramuscular |
| Subject | Influenza Virus Vaccine(no Preservative ) | Vaccine | 0.25 ml | Intramuscular |